Obesity and dyslipidemia.

By B. Howard, G. Ruotolo, D. Robbins. Endocrinology and metabolism clinics of North America (Print), 2003

780 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery

View Paper: https://www.semanticscholar.org/paper/75dc3f91ec7c06a7ccf98433635d0479f25a5367

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Mark I. McCarthy

Citations in the corpus

• Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts (2008, background): “Lipid-associated loci described in this study were not significantly associated with BMI in our cohorts, although obesity itself is correlated with lipid level”
• Dyslipidemia in Obesity: Mechanisms and Potential Targets (2013, background): “The concentrations of plasma apolipoprotein (apo) B are also often increased, partly due to the hepatic overproduction of apo B containing lipoproteins [6,7].”
• Mechanisms linking obesity with cardiovascular disease (2006, background): “Dyslipidaemia in obesity is characterized by increased levels of very low-density lipoprotein (VLDL) cholesterol, triacylglycerols and total cholesterol, an increase in small dense LDL particles, and lower high-density lipoprotein (HDL) cholesterol level”